Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gitsch

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|June 21, 1996
Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancerC Kainz, C Tempfer, P Kohlberger, et al.
Anticancer Research|January 1, 1997
pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parametersP Speiser, K Mayerhofer, E Kucera, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|March 1, 1995
[Comparison of surface tension with determination of the L/S ratio in amniotic fluid for prediction of fetal lung maturity]E A Joura, C Kainz, E M Joura, et al.
Journal of the American College of Surgeons|March 1, 1994
The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovariesC Kainz, L Prayer, G Gitsch, et al.
Breast Cancer Research and Treatment|January 4, 2008
The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer populationM Klar, A Jochmann, M Foeldi, et al.
Anticancer Research|May 1, 1995
Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancerG Sliutz, C Tempfer, C Kainz, et al.
Gynecologic Oncology|March 1, 1995
Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancerC Kainz, G Sliutz, G Mustafa, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[CD44 splice variants as prognostic factors in invasive cervix carcinoma]A Reinthaller, C Kainz, P Kohlberger, et al.
British Journal of Cancer|October 29, 1998
CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseasesC Tempfer, L Hefler, H Heinzl, et al.
Anticancer Research|January 29, 2000
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancerP L Moser, D G Kieback, L Hefler, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|June 21, 1996
Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancerC Kainz, C Tempfer, P Kohlberger, et al.
Anticancer Research|January 1, 1997
pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parametersP Speiser, K Mayerhofer, E Kucera, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|March 1, 1995
[Comparison of surface tension with determination of the L/S ratio in amniotic fluid for prediction of fetal lung maturity]E A Joura, C Kainz, E M Joura, et al.
Journal of the American College of Surgeons|March 1, 1994
The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovariesC Kainz, L Prayer, G Gitsch, et al.
Breast Cancer Research and Treatment|January 4, 2008
The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer populationM Klar, A Jochmann, M Foeldi, et al.
Anticancer Research|May 1, 1995
Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancerG Sliutz, C Tempfer, C Kainz, et al.
Gynecologic Oncology|March 1, 1995
Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancerC Kainz, G Sliutz, G Mustafa, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[CD44 splice variants as prognostic factors in invasive cervix carcinoma]A Reinthaller, C Kainz, P Kohlberger, et al.
British Journal of Cancer|October 29, 1998
CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseasesC Tempfer, L Hefler, H Heinzl, et al.
Anticancer Research|January 29, 2000
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancerP L Moser, D G Kieback, L Hefler, et al.
Pageof 13